Amicus Therapeutics, Inc. (NASDAQ:FOLD)

CAPS Rating: 2 out of 5

A clinical-stage biopharmaceutical company, which focused on the discovery, development and commercialization of novel small molecule, orally-administered drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diseases.

Recs

0
Player Avatar SanDieguito (< 20) Submitted: 12/20/2007 10:17:40 AM : Underperform Start Price: $9.99 FOLD Score: +45.01

down $5 to $10

Featured Broker Partners


Advertisement